00

Livzon Pharmaceutical Group IncSHE 000513 Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

4.062

Middle

Exchange

XSHE - Shenzhen Stock Exchange

000513.SZ Stock Analysis

00

Avoid

Based on Eyestock quantitative analysis, 000513.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

69/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-24.3 %

Greatly overvalued

Market cap $B

4.062

Dividend yield

3.59 %

Shares outstanding

935.55 B

Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 8,580 full-time employees. LIVZON PHARMACEUTICAL GROUP INC. is a China based company principally engaged in the research and development, production and sales of pharmaceutical products. The firm's main products include western medicine preparation such as gastrointestinal drugs, cardiovascular drugs and antimicrobial drugs and gonadotrophin drugs, Chinese medicine preparation, active pharmaceutical ingredient and intermediates, diagnostic reagents and equipments. The firm distributes its products in the domestic market and to overseas markets.

View Section: Eyestock Rating